These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1326 related items for PubMed ID: 8571323

  • 1. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 4. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 5. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA, Bonnar J.
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [Abstract] [Full Text] [Related]

  • 6. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP.
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [Abstract] [Full Text] [Related]

  • 7. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 8. Oral contraceptives and blood coagulation.
    Bonnar J, Sabra AM.
    J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
    [Abstract] [Full Text] [Related]

  • 9. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 10. Haemostatic changes and the oral contraceptive pill.
    Norris LA, Bonnar J.
    Baillieres Clin Obstet Gynaecol; 1997 Sep 22; 11(3):545-64. PubMed ID: 9488791
    [Abstract] [Full Text] [Related]

  • 11. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
    Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L.
    Thromb Haemost; 1999 Sep 22; 82(3):1112-6. PubMed ID: 10494773
    [Abstract] [Full Text] [Related]

  • 12. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR.
    Clin Obstet Gynaecol; 1984 Dec 22; 11(3):759-86. PubMed ID: 6509858
    [Abstract] [Full Text] [Related]

  • 13. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
    Lidegaard O.
    Ugeskr Laeger; 1993 Nov 01; 155(44):3538-45. PubMed ID: 8236574
    [Abstract] [Full Text] [Related]

  • 14. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.
    Contraception; 2004 Aug 01; 70(2):97-106. PubMed ID: 15288212
    [Abstract] [Full Text] [Related]

  • 15. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 01; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 16. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U, Dubois M.
    Contracept Fertil Sex (Paris); 1982 Sep 01; 10(9):551-60. PubMed ID: 12311606
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb 01; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

  • 18. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Feb 01; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 19. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR, Skouby SO, Sidelmann J, Jespersen J.
    Ugeskr Laeger; 1994 Jan 10; 156(2):187-90. PubMed ID: 8296409
    [Abstract] [Full Text] [Related]

  • 20. A multicentre study of coagulation and haemostatic variables during oral contraception: variations with four formulations. Task Force on Oral Contraceptives--WHO Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.
    Br J Obstet Gynaecol; 1991 Nov 10; 98(11):1117-28. PubMed ID: 1760424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.